Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 6/20 | 0.56 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.54 |
| ▸ | FCGRT | P55899 | 2/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.49 |
| ▸ | REN | P00797 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ovemotide SCHEMBL29413273 | 0.96 | CALCRL (0.56) | CALCRLRAMP1SLC6A2OPRD1REN | |
| Ovemotide SCHEMBL29538753 | 0.96 | CALCRL (0.56) | CALCRLRAMP1SLC6A2OPRD1REN | |
| SCHEMBL30974436 | 0.88 | CALCRL (0.52) | CALCRLSLC6A2OPRM1OPRD1 | |
| SCHEMBL29530922 | 0.85 | SLC6A2 (0.64) | CALCRLSLC6A2OPRM1OPRD1 | |
| SCHEMBL31575684 | 0.83 | KDM1A (0.56) | SLC6A2 | |
| SCHEMBL29657990 | 0.83 | SLC6A2 (0.59) | CALCRLSLC6A2OPRM1OPRD1OPRK1 | |
| SCHEMBL30792437 | 0.83 | NMUR2 (0.56) | — | |
| SCHEMBL29530548 | 0.83 | SLC6A2 (0.72) | CALCRLSLC6A2OPRM1OPRD1 | |
| SCHEMBL29531376 | 0.83 | SLC6A2 (0.72) | CALCRLSLC6A2OPRM1OPRD1 | |
| SCHEMBL29657973 | 0.82 | SLC6A2 (0.60) | CALCRLSLC6A2OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110651189-B | Peptide vaccine | 特雷斯生物有限公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-109843929-B | Proteolytically cleavable chimeric polypeptides and methods of use thereof | 加利福尼亚大学董事会 | 2024-07-05 | — | — | CN | disclosed |
| CN-108430497-B | Sugar-targeted therapeutic agents | 洛桑聚合联合学院 | 2024-05-07 | — | — | CN | disclosed |
| CN-110651188-B | Population-based immunogenic peptide identification platform | 特雷斯生物有限公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-111150841-B | Active immune regulation particle and preparation method and application thereof | 优锐生物医药科技(深圳)有限公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-114605547-A | Affinity entities with TCR-like antibody binding domains and uses thereof | 阿迪塞特生物公司 | 2022-06-10 | — | — | CN | disclosed |
| CN-114437217-A | Affinity entities with TCR-like antibody binding domains and uses thereof | 阿迪塞特生物公司 | 2022-05-06 | — | — | CN | disclosed |
| CN-108025045-B | Affinity entities for TCR-like antibody binding domains with high affinity and excellent specificity and uses thereof | 阿迪塞特生物公司 | 2022-04-26 | — | — | CN | disclosed |